Skip to Main Content

Paper Details

Clinical outcomes and immune responses to SARS-CoV-2 vaccination in severe aplastic anaemia.
Br J Haematol
4
2022
ACE2, Angiotensin II Converting Enzyme, CD4, CD8, COVID-19, IST, Patients, SAA, SARS-CoV, T-cell, ciclosporin, haemoglobin, neutrophil, patients, platelet, severe aplastic anaemia
Author NameAffiliation
Sandeep NarpalaVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Adrian B McDermottVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Neal S Youngand Blood Institutes, National Institutes of Health
  • 1 - 3

Datasets

Release 1.2